Literature DB >> 14667103

Coexistence of lupus anticoagulant and acquired haemophilia in a patient with monoclonal gammopathy of unknown significance.

A Taher1, R Abiad, I Uthman.   

Abstract

Acquired haemophilia or factor VIII (FVIII) deficiency, caused by FVIII inhibitor antibodies, is a very rare condition that commonly results in severe haemorrhagic complications. We report a case of acquired haemophilia presenting with a left calfnontraumatic haematoma. The patient was also found to have lupus anticoagulant (LAC). The simultaneous presence of LAC and FVIII inhibitor is exceedingly rare. The differentiation between these two conditions is crucial, because both result in a prolongation of the activated partial thromboplastin time test, which does not correct when mixed with the plasma of a normal control; however, the clinical manifestations range from thrombosis in the presence of LAC to massive haemorrhage with FVIII inhibitors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14667103     DOI: 10.1191/0961203303lu463cr

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  10 in total

Review 1.  The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network.

Authors:  Niels W C J van de Donk; Antonio Palumbo; Hans Erik Johnsen; Monika Engelhardt; Francesca Gay; Henrik Gregersen; Roman Hajek; Martina Kleber; Heinz Ludwig; Gareth Morgan; Pellegrino Musto; Torben Plesner; Orhan Sezer; Evangelos Terpos; Anders Waage; Sonja Zweegman; Hermann Einsele; Pieter Sonneveld; Henk M Lokhorst
Journal:  Haematologica       Date:  2014-03-21       Impact factor: 9.941

2.  Sequential thrombosis and bleeding in a woman with a prolonged activated partial thromboplastin time.

Authors:  Akpan Spencer; Michael I Pearce; Paul Rj Ames
Journal:  Thromb J       Date:  2011-10-27

Review 3.  Laboratory diagnosis of the lupus anticoagulant.

Authors:  Thomas L Ortel
Journal:  Curr Rheumatol Rep       Date:  2012-02       Impact factor: 4.592

Review 4.  Acquired Hemophilia A: Current Guidance and Experience from Clinical Practice.

Authors:  Allyson M Pishko; Bhavya S Doshi
Journal:  J Blood Med       Date:  2022-05-11

5.  IgMk paraprotein from gammopathy patient can bind to cardiolipin and interfere with coagulation assay: a case report.

Authors:  Xin-Yao Wu; Yu-Feng Yin; Jia-Lin Teng; Li-Wei Zhang; Cheng-de Yang
Journal:  BMC Immunol       Date:  2017-06-23       Impact factor: 3.615

6.  International recommendations on the diagnosis and treatment of acquired hemophilia A.

Authors:  Andreas Tiede; Peter Collins; Paul Knoebl; Jerome Teitel; Craig Kessler; Midori Shima; Giovanni Di Minno; Roseline d'Oiron; Peter Salaj; Victor Jiménez-Yuste; Angela Huth-Kühne; Paul Giangrande
Journal:  Haematologica       Date:  2020-05-07       Impact factor: 9.941

7.  Coexistence of Acquired Hemophilia and Antiphospholipid Serology in Monoclonal Gammopathy Patient.

Authors:  Nabil Belfeki; Sarra Hamrouni; Alessio Strazzulla; Sylvain Diamantis
Journal:  Int Med Case Rep J       Date:  2021-04-28

8.  Acquired hemophilia A in the setting of dual anticoagulation therapy and lupus anticoagulant: a case report.

Authors:  Victor Chen; Lauren C Roby; Stephanie Wentzel; Mingjia Li; Nicholas Jones
Journal:  J Med Case Rep       Date:  2022-05-03

9.  Hemostatic assessment, treatment strategies, and hematology consultation in massive postpartum hemorrhage: results of a quantitative survey of obstetrician-gynecologists.

Authors:  Andra H James; David L Cooper; Michael J Paidas
Journal:  Int J Womens Health       Date:  2015-11-04

10.  Concomitant factor VIII inhibitor and lupus anticoagulant in an asymptomatic patient.

Authors:  Jeremy W Jacobs; Savanah D Gisriel; Krishna Iyer; Henry M Rinder
Journal:  J Thromb Thrombolysis       Date:  2021-10-25       Impact factor: 2.300

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.